Faculty

  • Stacey Anderson, PhD
    Assistant Adjunct Professor

    Dr. Anderson's  research interests lie at the intersection of public health policy and social cognition.  She investigates marketing strategies that tap implicit constructs of self and perceptions of others, pair brand identities with personal identities, and encourage consumption of products detrimental to individual and public health. 

  • Dorie Apollonio, PhD
    Assistant Adjunct Professor in Clinical Pharmacy

    Research focuses on health policy and tobacco control, particularly the ways that clinical research is translated into policy interventions and public knowledge.

  • Mehrdad Arjomandi, MD
    Assistant Professor In-Residence of Medicine

    My primary research interest is studying the physiologic and inflammatory mechanisms of airway remodeling in various exposure-response models such as ozone-induced oxidative injury, allergic airway inflammation, and wood or tobacco smoke-induced airway injury.  

  • John Balmes, MD
    Prrofessor in Residence

    Dr. Balmes’ laboratory, the Human Exposure Laboratory (HEL), has been studying the respiratory and cardiovascular health effects of various air pollutants for the past 25 years. The HEL is currently investigating the respiratory and cardiovascular effects of secondhand tobacco smoke.

  • Richard Barnes, JD
    Health Sciences Clinical Professor, UCSF School of Pharmacy, Department of Clinical Pharmacy
    Adjunct Assistant Professor of Law, UC Hastings College of the Law

    Research of the tobacco industry documents in the UCSF Legacy Tobacco Documents Library, mentoring other CTCRE researchers, and researching and writing state tobacco control activity reports that explore the reasons for the successes, and the failures, of tobacco control efforts.

  • Joaquin Barnoya, MD MPH
    Assistant Adjunct Professor of Epidemiology

    Main interest is secondhand smoke and smoke-free environments.  In particular, Dr. Barnoya's work has documented the benefits of smoke-free environments and the effects of secondhand smoke on the cardiovascular system.  He works in the United States and Latin America.

  • Neal Benowitz, MD
    Professor of Medicine, Bioengineering and Therapeutic Sciences

    Research focuses primarily on the human pharmacology of nicotine and other stimulant drugs.  Dr. Benowitz's laboratory has conducted studies on the disposition kinetics, metabolism and pharmocodynamics of nicotine, with an emphasis on the role of nicotine and maintaining nicotine addiction in causing tobacco-related diseases, including cardiovascular disease and cancer.

  • Lisa Bero, PhD
    Professor of Clinical Pharmacy and Institute for Health Policy, UCSF

    Dr. Bero is a pharmacologist with primary interest in how clinical and basic sciences are translated into clinical practice and health policy.  She has developed and validated methods for assessing the quality of research and scientific publication.

  • Paul Blanc, MD MSPH
    Professor of Medicine, Endowed Chair Occupational and Environmental Medicine

    Paul Blanc is Chief of the Division of Occupational and Environmental Medicine. He has authored numerous scholarly publications on the subject of toxic exposures and illness and is author of How Everyday Products Make People Sick (2009, UC Press).

  • Patricia Buffler, PhD, MPH, CPH
    Professor of Epidemiology and Dean Emerita, University of California, Berkeley

    Dr. Buffler is an epidemiologist with a primary interest in cancer and tobacco related malignancies. She has conducted research on active smoking and respiratory cancer, and passive exposures to tobacco smoke and lung cancer in nonsmokers. 

  • Carolyn Calfee, MD
    Assistant Professor of Medicine

    Research focuses on the effects of active and passive smoking on susceptibility to acute lung injury, a major cause of respiratory failure in critically ill patients. In addition, she is interested in the use of biomarkers to measure cigarette smoke exposure.

  • Timothy Carmody, PhD
    Clinical Professor, Department of Psychiatry

    Dr. Carmody's work focuses on the treatment of nicotine dependence in adult chronic smokers.

  • Janine Cataldo, PhD RN
    Assistant Professor, Department of Physiological Nursing - Gerontology

    Dr. Cataldo's research and clinical foci include: the impact of tobacco industry activities on older smokers and geriatric science; stigma, symptom burden, and quality of life among lung cancer patients; and use of virtual worlds as an intervention to decrease stigma and improve patient-client communication.

  • Robin Corelli, PharmD
    Professor of Clinical Pharmacy

    Primary interest in tobacco cessation education and training. Dr. Corelli has co-coordinated, with other Tobacco Center members (Drs. Hudmon and Kroon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for students in the health professions.  

  • Kevin Delucchi, PhD
    Professor of Biostatistics in Psychiatry

    Dr. Delucchi is a quantitative expert specializing in psycho-social research.

  • Erika Froelicher, RN, PhD
    Professor, Dept. of Physiological Nursing, UCSF School of Nursing

    Primary, secondary and tertiary (rehabilitation) prevention through nursing interventions to reduce cardiovascular disease risk factors (exercise, blood pressure, lipid, obesity, smoking cessation and relapse prevention) as well as depression and social isolation. I also have a strong interest in physiological, psychosocial, and economic issues relevant to Expertise in methods, design, and epidemiology.

  • Stanton Glantz, PhD
    Professor of Medicine

    Dr. Glantz, the American Legacy Foundation Distinguished Professor of Tobacco Control, conducts research on a wide range of topics ranging from the health effects of secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies.

  • Warren Gold, MD
    Professor of Medicine

    Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function.

  • Esteban González Burchard, MD
    Associate Professor of Pharmacy and Medicine

    The overall goal of my research group is to identify and characterize genetic, environmental and social factors that predispose to asthma and modify drug response (pharmacogenetics). In addition, we are interested in how racially-specific genetic diffs. modify disease and response to treatment.

  • Lawrence Green, DrPH
    Professor of Epidemiology and Biostatistics

    Research on health promotion, including tobacco control, with particular emphasis on knowledge dissemination, transfer, program planning and implementation strategies. His interest is in making practice more evidence-based by making evidence more practice-based.

  • Joseph Guydish, PhD MPH
    Professor in Residence

    Research on access, delivery, and organization of substance abuse treatment services, treatment effectiveness, and adoption of new treatments into practice settings. He is currently testing an organizational change intervention for treatment programs in tobacco dependence.

  • Sharon Hall, PhD
    Professor in Residence, Psychiatry

    Major areas of research are clinical trials for the treatment of nicotine dependence, with emphasis on treatments that reflect a chronic disease model, and on complex populations.

  • Bonnie Halpern-Felsher, PhD
    Professor

    Dr. Bonnie Halpern-Felsher is a Professor in the Division of Adolescent Medicine, Department of Pediatrics, University of California, San Francisco. She is also a faculty member in UCSF’s Psychology and Medicine Postdoctoral Program, The Center for Health and Community, the Center for Tobacco Control Research and Education, the Comprehensive Cancer Center, and the Robert Wood Johnson Scholars Program. She is also the Co-Director of the Postdoctoral Research Fellowship Training in Adolescent Medicine and the Associate Director of the General Pediatrics Fellowship.

  • Katharine Hammond, PhD
    Professor of Environmental Health Sciences, UC Berkeley

    Research focuses on exposure assessment as it relates to human health; within this broad category there are three major foci: occupational health, environmental health, and secondhand smoke.

  • Robert Hiatt, MD PhD
    Professor

    Primarily focused on cancer epidemiology and studies of cancer etiology, early development, the environment and social determinants. 

  • Lisa Kroon, PharmD
    Professor of Clinical Pharmacy

    Interests in tobacco cessation education and training of health professionals. She has co-coordinated, with other Tobacco Center members (Drs. Corelli and Hudmon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for health professional students and practitioners. She practices at the UCSF adult diabetes and primary care clinics, where she provides smoking cessation counseling. She also is a member of the UCSF Tobacco Education Center, where she provides medication therapy information and advice during their group cessation classes.

  • James Lightwood, PhD
    Associate Adjunct Professor.

    Research program involves estimating the changes in direct healthcare costs due to changes in smoking behavior in large populations, and changes in exposure to passive smoking and health care cost and utilization attributable to adoption of smoke-free laws.

  • Pamela Ling, MD MPH
    Associate Professor In Residence

    Dr. Ling studies tobacco industry marketing strategies targeting young adults, women, and other high risk population, and new smokeless tobacco marketing strategies.  She also studies how to use tobacco industry marketing strategies to improve tobacco control programs.

  • Ruth Malone, PhD RN
    Professor and Chair, Department of Social & Behavioral Sciences

    Research focuses on tobacco industry activities aimed at undermining public health, strategic positioning and messaging, marginalized populations, and emerging developments in the social construction of tobacco use.

  • Wendy Max, PhD
    Professor In Residence

    Research focuses on the economic impact of tobacco on health and healthcare expenditures.  Dr. Max and her colleagues have worked for over two decades to develop models to estimate the  costs associated with smoking and exposure to secondhand smoke.    

  • Tung Nguyen, MD
    Professor of Clinical Medicine

    Dr. Nguyen is Professor of  Clinical Medicine at UCSF, where he provides primary care to a diverse patient population and teaches students, clinicians, and researchers. He is the Co-Director of the Vietnamese Community Health Promotion Project, a community-academic research unit working on Asian health issues since 1986.  Dr. Nguyen’s research focuses on addressing health disparities using community-based participatory research (CBPR) methods. Dr.

  • Eliseo Pérez-Stable, MD
    Professor of Medicine

    Research is focused on health disparities with a special emphasis on Latino health care and cancer control.  He is Co-PI of the NCI funded Redes En Accion National Latino Cancer Control Research and Education Network.  He collaborates with new investigators from several institutions to help develop the tobacco control research agenda for minority populations in the US.  Dr. Pérez-Stable also has an R01 grant from the Fogarty International Center/NIDA to strengthen capacity in tobacco control research and implement projects in Argentina.

  • Jodi Prochaska, PhD MPH
    Adjunct Professor of Medicine, UCSF
    Associate Professor of Medicine, Stanford Prevention Research Center, Stanford Univ

    Judith (Jodi) Prochaska, PhD, MPH, is an Associate Professor of Medicine with the Stanford Prevention Research Center at Stanford University and an Adjunct Professor of Medicine at UCSF. She is a mentor of fellows in the CTCRE's NCI-funded R25 postdoctoral training program.

  • Danielle Ramo, PhD
    Assistant Adjunct Professor

    My research centers on understanding the role of lifespan development in the etiology, expression, and treatment of addictive disorders.  I am interested in differences in use patterns, relapse, and treatment needs across the lifespan, from adolescence to adulthood.

  • Rita Redberg, MD, MS
    Professor

    Dr. Rita Redberg is a cardiologist, and directs women’s cardiovascular services and the UCSF Flight Attendant Clinic. Her research interests are in the effects of secondhand smoke and other work related conditions (radiation) on flight attendants, as well as in technology assessment and preventive cardiology.

  • Mark Rubinstein, MD
    Assistant Adjunct Professor

    Research program centers on the development of nicotine dependence in adolescents.

  • Suzaynn Schick, PhD
    Assistant Adjunct Professor of Medicine

    Dr. Suzaynn Schick studies the effects of exposure to secondhand cigarette smoke on the upper and lower respiratory tract in human subjects and the chemical and physical changes that occur in aging secondhand smoke.  Dr. Schick received her BS in Cell and Molecular Biology and the University of Washington and her PhD in Biomedical Sciences at the University of California, San Francisco.  She did postdoctoral training under Professors Stan Glantz and John Balmes and now leads her own group in the Human Exposure Laboratory at San Francisco General Hospital campus. 

  • Steven Schroeder, MD
    Distinguished Professor of Health and Health Care

    Research focuses on determinants of medical expenditures, efficacy of medical cost containment, quality of care, and tobacco control with an emphasis on smoking cessation.  

  • Joel Simon, MD, MPH
    Professor of Clinical Medicine

    Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation.   

  • Elizabeth Smith, PhD
    Associate Adjunct Professor

    Research has focused on "legitimate" tobacco industry activities, and tobacco industry relationships with other groups.  

  • Anna Song, PhD
    Assistant Professor, University of California, Merced School of Social Sciences, Humanities, and Arts

    Dr. Song is a health psychologist who studies adolescent and young adult decision-making processes underlying smoking behaviors. Her research focuses on ethnic/class disparities, smoking-related perceptions, and personality and socio-cognitive factors that shape smoking-related attitudes.

  • Matthew Springer, PhD
    Associate Professor of Medicine

    Research interests include cell therapy and gene therapy approaches to the study of cardiovascular disease, with the goals of exploring potential treatments and understanding underlying mechanisms involved in angiogenesis, vascular function, and treatments for myocardial infarction.

  • Hai-Yen Sung, PhD
    Adjunct Professor, Institute for Health & Aging

    Research focuses on costs of smoking, costs of illness, evaluation of the economic impact of tobacco taxation and other tobacco control policies, secondhand smoke exposure, and cancer screening and outcomes.

  • Janice Tsoh, PhD
    Associate Adjunct Professor

    Research program focuses on smoking cessation treatment in special populations including Asian Americans, and clients in substance abuse treatment. She is interested in the use of social network and support in promoting utilization of and delivering evidence-based treatment in underserved populations.   

  • Margaret Walsh, EdD
    Professor, Department of Preventive & Restorative Dental Sciences

    Major area of research is the prevention and treatment of smokeless tobacco use among high-risk groups in novel community-based settings (i.e., rural high schools, college and professional athletic programs, dental settings, and the Internet).

  • Prescott Woodruff, MD, MPH
    Assistant Professor of Medicine in Residence

    Research program includes clinical and basic science approaches to study the effects of cigarette smoke on lung inflammation. He is also the Principal Investigator on the NIH-funded Spiromics Project and a Co-investigator on the COPD Clinical Research Network.

  • Valerie Yerger, ND
    Assistant Adjunct Professor

    Dr. Yerger's research focuses on the tobacco industry’s targeting of African American communities, the use of menthol in tobacco products, smoke-free policies in multi-unit housing.